These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 3073650)
1. Overview: rational basis for development of fluoropyrimidine/5-formyltetrahydrofolate combination chemotherapy. Huennekens FM; Montejano YD; Vitols KS Adv Exp Med Biol; 1988; 244():1-11. PubMed ID: 3073650 [TBL] [Abstract][Full Text] [Related]
2. The effect of derivatives of folic acid on the fluorodeoxyuridylate-thymidylate synthetase covalent complex in human colon xenografts. Houghton JA; Schmidt C; Houghton PJ Eur J Cancer Clin Oncol; 1982 Apr; 18(4):347-54. PubMed ID: 6889511 [TBL] [Abstract][Full Text] [Related]
3. Antitumour effects of pure diastereoisomers of 5-formyltetrahydrofolate in hepatic transplants of a rodent colon carcinoma model. Carlsson G; Gustavsson B; Frösing R; Odin E; Hafström LO; Spears CP; Larsson PA Biochem Pharmacol; 1995 Oct; 50(9):1347-51. PubMed ID: 7503782 [TBL] [Abstract][Full Text] [Related]
4. Methylenetetrahydrofolate reductase polymorphism is associated with folate pool in gastrointestinal cancer tissue. Kawakami K; Omura K; Kanehira E; Watanabe G Anticancer Res; 2001; 21(1A):285-9. PubMed ID: 11299748 [TBL] [Abstract][Full Text] [Related]
5. 5-Fluorouracil combined with the [6S]-stereoisomer of folinic acid in high doses for treatment of patients with advanced colorectal carcinoma. A phase I-II study of two consecutive regimens. Machover D; Grison X; Goldschmidt E; Zittoun J; Metzger G; Richaud J; Lotz JP; André T; Hannoun L; Marquet J Ann Oncol; 1993; 4 Suppl 2():29-35. PubMed ID: 8353102 [TBL] [Abstract][Full Text] [Related]
6. Thymidylate synthase level as the main predictive parameter for sensitivity to 5-fluorouracil, but not for folate-based thymidylate synthase inhibitors, in 13 nonselected colon cancer cell lines. van Triest B; Pinedo HM; van Hensbergen Y; Smid K; Telleman F; Schoenmakers PS; van der Wilt CL; van Laar JA; Noordhuis P; Jansen G; Peters GJ Clin Cancer Res; 1999 Mar; 5(3):643-54. PubMed ID: 10100718 [TBL] [Abstract][Full Text] [Related]
7. Mutation(s) of the thymidylate synthase gene of human adenocarcinoma cells causes a thymidylate synthase-negative phenotype that can be attenuated by exogenous folates. Houghton PJ; Rahman A; Will CL; Dolnick BJ; Houghton JA Cancer Res; 1992 Feb; 52(3):558-65. PubMed ID: 1732043 [TBL] [Abstract][Full Text] [Related]
8. [Comparison between leucovorin and cisplatin as a modulator of 5-fluorouracil]. Iba T; Yagi Y; Kidokoro A; Fukunaga T Gan To Kagaku Ryoho; 1993 Mar; 20(4):479-83. PubMed ID: 8452385 [TBL] [Abstract][Full Text] [Related]
10. Thymidylate synthase inhibition after administration of fluorouracil with or without leucovorin in colon cancer patients: implications for treatment with fluorouracil. Peters GJ; van der Wilt CL; van Groeningen CJ; Smid K; Meijer S; Pinedo HM J Clin Oncol; 1994 Oct; 12(10):2035-42. PubMed ID: 7931471 [TBL] [Abstract][Full Text] [Related]
11. Accumulation of tetrahydrofolates in human plasma after leucovorin administration. Bunni MA; Rembiesa BM; Priest DG; Sahovic E; Stuart R Cancer Chemother Pharmacol; 1989; 23(6):353-7. PubMed ID: 2785439 [TBL] [Abstract][Full Text] [Related]
12. Preliminary results of a phase II trial for the treatment of metastatic breast cancer with 5-fluorouracil and leucovorin. Allegra CJ; Chabner BA; Sholar PW; Bagley C; Drake JC; Lippman ME NCI Monogr; 1987; (5):199-202. PubMed ID: 3501543 [TBL] [Abstract][Full Text] [Related]
13. Biphasic binding of 5-fluoro-2'-deoxyuridylate to human thymidylate synthase. Reilly RT; Barbour KW; Dunlap RB; Berger FG Mol Pharmacol; 1995 Jul; 48(1):72-9. PubMed ID: 7623777 [TBL] [Abstract][Full Text] [Related]
14. [The intratumoral levels of thymidylate synthetase and folate in gastric and colon cancer]. Iba T; Yagi Y; Kidokoro A; Ishi K; Koyatsu J Gan To Kagaku Ryoho; 1998 Jul; 25(8):1165-71. PubMed ID: 9679579 [TBL] [Abstract][Full Text] [Related]
15. Leucovorin enhancement of the effects of the fluoropyrimidines on thymidylate synthase. Morgan RG Cancer; 1989 Mar; 63(6 Suppl):1008-12. PubMed ID: 2521810 [TBL] [Abstract][Full Text] [Related]
16. Functional effects of a naturally occurring amino acid substitution in human thymidylate synthase. Hughey CT; Barbour KW; Berger FG; Berger SH Mol Pharmacol; 1993 Aug; 44(2):316-23. PubMed ID: 8355668 [TBL] [Abstract][Full Text] [Related]
17. Mechanisms of innate resistance to thymidylate synthase inhibition after 5-fluorouracil. Spears CP; Gustavsson BG; Berne M; Frösing R; Bernstein L; Hayes AA Cancer Res; 1988 Oct; 48(20):5894-900. PubMed ID: 3167844 [TBL] [Abstract][Full Text] [Related]
18. Stereochemical mechanism of action for thymidylate synthase based on the X-ray structure of the covalent inhibitory ternary complex with 5-fluoro-2'-deoxyuridylate and 5,10-methylenetetrahydrofolate. Matthews DA; Villafranca JE; Janson CA; Smith WW; Welsh K; Freer S J Mol Biol; 1990 Aug; 214(4):937-48. PubMed ID: 2201779 [TBL] [Abstract][Full Text] [Related]
19. Thymidylate synthase expression and response to neoadjuvant chemotherapy in patients with advanced head and neck cancer. Johnston PG; Mick R; Recant W; Behan KA; Dolan ME; Ratain MJ; Beckmann E; Weichselbaum RR; Allegra CJ; Vokes EE J Natl Cancer Inst; 1997 Feb; 89(4):308-13. PubMed ID: 9048835 [TBL] [Abstract][Full Text] [Related]
20. Time course of inhibition of thymidylate synthase in patients treated with fluorouracil and leucovorin. Peters GJ; van Groeningen CJ; van der Wilt CL; Meijer S; Smid K; Laurensse E; Pinedo HM Semin Oncol; 1992 Apr; 19(2 Suppl 3):26-35. PubMed ID: 1557655 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]